HSDT RSI Chart
Last 7 days
-7.4%
Last 30 days
-70.9%
Last 90 days
-74.1%
Trailing 12 Months
-81.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 668.0K | 0 | 0 | 0 |
2023 | 708.0K | 845.0K | 792.0K | 644.0K |
2022 | 628.0K | 676.0K | 763.0K | 787.0K |
2021 | 538.5K | 476.5K | 454.5K | 522.0K |
2020 | 1.0M | 641.5K | 622.5K | 661.5K |
2019 | 732.6K | 987.3K | 1.2M | 1.5M |
2018 | 0 | 353.1K | 415.6K | 478.0K |
2016 | 103.3K | 165.8K | 228.2K | 290.7K |
2015 | 0 | 0 | 0 | 0 |
2014 | 807.4K | 0 | 0 | 0 |
2013 | 4.3M | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 14, 2023 | andreeff dane | bought | 40,475 | 8.095 | 5,000 | president and ceo |
Dec 01, 2023 | andreeff dane | bought | 12,934 | 6.448 | 2,006 | president and ceo |
Dec 01, 2023 | andreeff dane | bought | 4,146 | 6.448 | 643 | president and ceo |
Nov 30, 2023 | andreeff dane | bought | 12,740 | 6.3704 | 2,000 | president and ceo |
Nov 30, 2023 | andreeff dane | bought | 4,083 | 6.3704 | 641 | president and ceo |
Aug 30, 2023 | andreeff dane | bought | 38,211 | 7.6423 | 5,000 | president and ceo |
Aug 28, 2023 | andreeff dane | bought | 32,338 | 6.3684 | 5,078 | president and ceo |
May 24, 2023 | buckman paul | acquired | - | - | 83,054 | - |
May 24, 2023 | straw edward m | acquired | - | - | 83,054 | - |
May 24, 2023 | walter blane | acquired | - | - | 83,054 | - |
Which funds bought or sold HSDT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | MORGAN STANLEY | unchanged | - | -9.00 | 23.00 | -% |
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 432 | 432 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -28.12 | -5,364 | 5,842 | -% |
May 15, 2024 | Royal Bank of Canada | unchanged | - | - | - | -% |
May 15, 2024 | CITADEL ADVISORS LLC | new | - | 64,352 | 64,352 | -% |
May 14, 2024 | TORONTO DOMINION BANK | unchanged | - | -15.00 | 41.00 | -% |
May 13, 2024 | UBS Group AG | sold off | -100 | -1,736 | - | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | unchanged | - | -186 | 489 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 20.00 | -5.00 | 35.00 | -% |
May 10, 2024 | BlackRock Inc. | sold off | -100 | -40,735 | - | -% |
Unveiling Helius Medical Technologies Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Helius Medical Technologies Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Helius Medical Technologies Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 0.7% | 135,000 | 134,000 | 143,000 | 256,000 | 111,000 | 282,000 | 196,000 | 119,000 | 190,000 | 258,000 | 109,000 | 71,000 | 84,000 | 190,500 | 131,000 | 133,000 | 207,000 | 151,500 | 150,000 | 518,000 | 677,000 |
Gross Profit | -72.7% | 12,000 | 44,000 | -44,000 | 72,000 | -11,000 | 132,000 | 95,000 | 31,000 | 66,000 | 128,500 | 23,000 | 4,000 | 69,000 | -10,500 | 109,000 | 69,000 | 106,000 | -157,000 | 61,000 | 306,000 | 441,000 |
Operating Expenses | 49.7% | 3,428,000 | 2,290,000 | 3,109,000 | 3,291,000 | 3,799,000 | 2,801,000 | 4,948,000 | 3,461,000 | 4,630,000 | 4,230,500 | 4,396,000 | 6,170,000 | 3,570,000 | 2,991,500 | 3,769,000 | 3,791,000 | 4,108,000 | 5,468,000 | 5,797,000 | 6,120,000 | 7,262,000 |
S&GA Expenses | 61.3% | 2,633,000 | 1,632,000 | 2,196,000 | 2,569,000 | 2,874,000 | 1,967,000 | 3,393,000 | 2,461,000 | 2,819,000 | 2,376,000 | 2,859,000 | 4,744,000 | 2,197,000 | 2,088,500 | 2,370,000 | 2,394,000 | 2,862,000 | 3,805,000 | 4,291,000 | 3,845,000 | 4,581,000 |
R&D Expenses | 21.2% | 788,000 | 650,000 | 722,000 | 684,000 | 886,000 | 794,000 | 751,000 | 953,000 | 1,764,000 | 1,808,000 | 1,489,000 | 1,377,000 | 1,316,000 | 827,000 | 1,327,000 | 1,308,000 | 1,120,000 | 1,599,000 | 1,506,000 | 2,275,000 | 2,681,000 |
EBITDA Margin | 3.4% | -13.21 | -13.67 | -15.98 | -11.85 | -17.17 | -17.79 | -23.63 | -26.67 | -28.70 | -34.52 | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -140.8% | -2,516,000 | -1,045,000 | -3,663,000 | -1,648,000 | -2,494,000 | -4,886,000 | -1,030,000 | -3,810,000 | -4,346,000 | - | -4,687,000 | -5,981,000 | - | - | - | - | - | - | - | - | - |
EBT Margin | 3.4% | -13.28 | -13.74 | -16.02 | -11.90 | -17.26 | -17.88 | -23.76 | -26.82 | -28.87 | -34.74 | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -140.8% | -2,516,000 | -1,045,000 | -3,663,000 | -1,648,000 | -2,494,000 | -4,886,000 | -1,030,000 | -3,810,000 | -4,346,000 | -4,102,000 | -4,687,000 | -5,981,000 | -3,362,000 | -2,535,000 | -3,477,000 | -3,361,000 | -4,757,000 | -5,331,000 | -5,588,000 | -186,000 | 1,324,000 |
Net Income Margin | 3.4% | -13.28 | -13.74 | -16.02 | -11.90 | -17.26 | -17.88 | -17.42 | -25.07 | -30.44 | -34.74 | -36.45 | -32.22 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -47.6% | -3,006,000 | -2,037,000 | -2,458,000 | -2,741,000 | -3,209,000 | -2,141,000 | -3,828,000 | -3,674,000 | -4,684,000 | -3,468,000 | -3,265,000 | -3,769,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -25.2% | 5,757 | 7,692 | 8,854 | 10,753 | 13,755 | 17,287 | 18,859 | 6,546 | 9,618 | 14,102 | 7,879 | 10,717 | 14,664 | 6,547 | 6,026 | 8,704 | 8,461 | 10,347 | 12,880 | 18,197 | 22,498 |
Current Assets | -25.7% | 5,524 | 7,438 | 8,576 | 10,265 | 13,209 | 16,697 | 18,217 | 5,064 | 8,026 | 12,594 | 6,238 | 8,985 | 12,863 | 4,685 | 4,136 | 6,743 | 5,875 | 7,241 | 11,228 | 16,529 | 20,831 |
Cash Equivalents | -30.8% | 3,600 | 5,200 | 6,596 | 8,600 | 11,300 | 14,549 | 16,658 | 3,273 | 6,310 | 11,005 | 4,700 | 7,400 | 11,397 | 3,331 | 2,680 | 5,264 | 4,360 | 5,459 | 9,019 | 14,311 | 18,656 |
Inventory | -16.0% | 384 | 457 | 521 | 563 | 617 | 589 | 609 | 577 | 520 | 476 | 538 | 507 | 484 | 389 | 572 | 570 | 594 | 598 | 1,289 | 902 | 731 |
Net PPE | -2.2% | 174 | 178 | 182 | 345 | 354 | 347 | 348 | 365 | 380 | 409 | 451 | 449 | 477 | 486 | 463 | 478 | 678 | 712 | 725 | 711 | 693 |
Goodwill | - | - | - | - | - | - | - | - | 753 | 777 | 763 | 762 | 783 | 769 | 759 | 725 | 710 | 686 | 1,242 | - | - | - |
Liabilities | -29.4% | 3,771 | 5,342 | 5,833 | 6,181 | 7,688 | 9,136 | 5,898 | 2,044 | 2,488 | 2,846 | 2,842 | 2,350 | 2,766 | 2,676 | 2,829 | 2,308 | 3,252 | 4,512 | 4,058 | 5,415 | 10,480 |
Current Liabilities | -16.1% | 1,576 | 1,879 | 1,435 | 1,524 | 1,789 | 1,988 | 1,200 | 1,777 | 2,199 | 2,653 | 2,642 | 2,137 | 2,534 | 2,424 | 2,565 | 2,027 | 2,617 | 3,802 | 3,547 | 4,861 | 9,883 |
Shareholder's Equity | -15.5% | 1,986 | 2,350 | 3,021 | 4,572 | 6,067 | 8,151 | 12,961 | 4,502 | 7,130 | 11,256 | 5,037 | 8,367 | 11,898 | 3,871 | 3,197 | 6,396 | 5,209 | 5,835 | 8,822 | 12,782 | 12,018 |
Retained Earnings | -1.5% | -162,473 | -160,000 | -158,900 | -155,249 | -153,601 | -151,107 | -146,221 | -145,200 | -141,381 | -137,035 | -132,900 | -128,200 | -122,265 | -118,903 | -116,368 | -112,891 | -109,530 | -104,773 | -99,442 | -93,854 | -93,668 |
Additional Paid-In Capital | 1.1% | 164,843 | 162,979 | 162,391 | 160,443 | 160,023 | 159,645 | 159,386 | 150,665 | 149,834 | 149,412 | 139,093 | 138,023 | 135,388 | 123,872 | 120,257 | 119,763 | 114,967 | 111,509 | 108,997 | 107,437 | 106,363 |
Shares Outstanding | 24.2% | 887 | 715 | 688 | 565 | 564 | 564 | 171 | 77.00 | 76.00 | 76.00 | 47.00 | 44.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 5,260 | - | - | - | 4,729 | - | - | - | 37,215 | - | - | - | 17,405 | - | - | - | 41,929 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -47.5% | -3,001 | -2,034 | -2,452 | -2,740 | -3,190 | -2,143 | -3,821 | -3,664 | -4,682 | -3,463 | -3,235 | -3,769 | -2,921 | -2,171 | -2,588 | -3,228 | -3,751 | -4,539 | -5,246 | -4,414 | -6,800 |
Share Based Compensation | 0% | 401 | 401 | 403 | 420 | 405 | 232 | 1,441 | 179 | 402 | 356 | 740 | 2,629 | 527 | 508 | 450 | 729 | 842 | 1,355 | 1,560 | 941 | 835 |
Cashflow From Investing | -66.7% | -5.00 | -3.00 | -6.00 | -1.00 | -19.00 | 2.00 | -7.00 | -10.00 | 4.00 | -5.00 | -30.00 | - | -21.00 | -49.00 | -11.00 | 61.00 | -10.00 | -509 | -56.00 | -43.00 | -161 |
Cashflow From Financing | 135.2% | 1,463 | 622 | - | - | - | - | 17,249 | 637 | -17.00 | 9,773 | 519 | -186 | 11,020 | 2,911 | - | 4,075 | 2,652 | 1,490 | - | 123 | 40.00 |
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue | ||
Product sales, net | $ 124 | $ 106 |
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] | us-gaap:ProductMember | us-gaap:ProductMember |
Other revenue | $ 11 | $ 5 |
Total revenue | 135 | 111 |
Cost of revenue | ||
Cost of revenue | $ 123 | $ 122 |
Cost, Product and Service [Extensible Enumeration] | us-gaap:ProductMember | us-gaap:ProductMember |
Gross profit (loss) | $ 12 | $ (11) |
Operating expenses | ||
Selling, general and administrative expenses | 2,633 | 2,874 |
Research and development expenses | 788 | 886 |
Amortization expense | 7 | 39 |
Total operating expenses | 3,428 | 3,799 |
Loss from operations | (3,416) | (3,810) |
Nonoperating income (expense) | ||
Interest income (expense), net | (8) | 100 |
Change in fair value of derivative liability | 1,142 | 1,221 |
Foreign exchange loss | (288) | (5) |
Other income, net | 54 | |
Nonoperating income, net | 900 | 1,316 |
Loss before provision for income taxes | (2,516) | (2,494) |
Provision for income taxes | ||
Net loss | (2,516) | (2,494) |
Other comprehensive income (loss) | ||
Foreign currency translation adjustments | 288 | 5 |
Comprehensive loss | $ (2,228) | $ (2,489) |
Loss per share | ||
Basic (in dollar per share) | $ (3.08) | $ (4.42) |
Diluted (in dollar per share) | $ (3.08) | $ (4.42) |
Weighted average number of common shares outstanding | ||
Basic (in shares) | 817,327 | 564,134 |
Diluted (in shares) | 817,327 | 564,134 |
Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 3,638 | $ 5,182 |
Accounts receivable, net | 49 | 117 |
Other receivables | 513 | 520 |
Inventory, net | 384 | 457 |
Prepaid expenses and other current assets | 940 | 1,162 |
Total current assets | 5,524 | 7,438 |
Property and equipment, net | 174 | 178 |
Intangible assets, net | 17 | 24 |
Operating lease right-of-use asset, net | 42 | 52 |
Total assets | 5,757 | 7,692 |
Current liabilities | ||
Accounts payable | 814 | 531 |
Accrued and other current liabilities | 674 | 1,260 |
Current portion of operating lease liabilities | 46 | 45 |
Current portion of deferred revenue | 42 | 43 |
Total current liabilities | 1,576 | 1,879 |
Operating lease liabilities, net of current portion | 12 | |
Deferred revenue, net of current portion | 115 | 128 |
Derivative liability | 2,080 | 3,323 |
Total liabilities | 3,771 | 5,342 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity | ||
Class A common stock, $0.001 par value; 150,000,000 shares authorized; 887,847 and 714,590 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 1 | 1 |
Additional paid-in capital | 164,843 | 162,979 |
Accumulated deficit | (162,473) | (159,957) |
Accumulated other comprehensive loss | (385) | (673) |
Total stockholders' equity | 1,986 | 2,350 |
Total liabilities and stockholders' equity | $ 5,757 | $ 7,692 |